Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CFO resigned
CC transcript
Appointed director
|
|
OSIRIS THERAPEUTICS, INC. (OSIR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/17/2019 |
GN
| Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc |
| 03/14/2019 |
GN
| OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout |
| 02/28/2019 |
GN
| Predictive Technology Group Names Jay M. Moyes to Its Board of Directors |
| 11/26/2018 |
GN
| Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer |
| 11/07/2018 |
GN
| Osiris Therapeutics, Inc Reports Third Quarter 2018 Results |
| 10/30/2018 |
GN
| Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada |
| 10/02/2018 |
GN
| Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living Tissues is an Alternative to Cryopreservation with the Convenience of Ambient Storage |
| 09/17/2018 |
GN
| Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018 |
| 03/10/2017 |
GN
| Osiris Receives Notice of Delisting from NASDAQ |
| 02/10/2017 |
GN
| Osiris Appoints Uwe Sommer and Thomas Knapp to its Board of Directors |
|
|